Traynor Capital Management, Inc. Gossamer Bio, Inc. Transaction History
Traynor Capital Management, Inc.
- $1.17 Billion
- Q1 2025
A detailed history of Traynor Capital Management, Inc. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Traynor Capital Management, Inc. holds 23,272 shares of GOSS stock, worth $48,405. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,272
Previous 14,000
66.23%
Holding current value
$48,405
Previous $12,000
108.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GOSS
# of Institutions
125Shares Held
161MCall Options Held
2.11MPut Options Held
57.8K-
Octagon Capital Advisors LP New York, NY18.4MShares$38.2 Million6.72% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$37.6 Million1.89% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$21 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$16.8 Million7.27% of portfolio
-
Acadian Asset Management LLC Boston, MA6.36MShares$13.2 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $195M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...